Preterm labor is the leading cause of neonatal morbidity and mortality in clinical practice. b-Adrenoceptor (AR) agonists such as ritodrine and terbutaline are the drugs of first choice for preventing this preterm labor. However, the usefulness of these drugs is limited by the occurrence of side effects such as maternal tachycardia and metabolic systems. To resolve this problem, we have developed a new selective b2-AR agonist, bis(2-{[(2S)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl}amino)-1,2,3,4-tetrahydronaphthalen-7-yl]oxy}-N,N-dimethylacetamide) sulfate (KUR-1246), as shown in Fig. 1 . KUR-1246 at doses of 0.13 mg/ kg/min intravenously suppressed 30% of the uterine contractions in late pregnant rats. The inhibitory potency with which KUR-1246 produced this effect was about 6 times that of terbutaline, and 400 times that of ritodrine. Moreover, it has been reported that KUR-1246 has an excellent selectivity for the myometrial b2-AR. 1) We now require a large amount of optically pure KUR-1246 for further evaluation of this compound as a uterine relaxant. In this paper, we describe the convenient and practical method for the synthesis of KUR-1246.
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Our group reported the synthesis of KUR-1246, as shown in Chart 1.
2) The racemic mandelic acid derivative 2 was synthesized from the O-protected hydroxyethylphenol 1 through bromination, lithiation and reaction with diethyl oxalate under Ϫ95°C, and hydrolysis with aqueous NaOH. The condensation of the acid 2 and (S)-2-amino-7-hydroxytetraline hydrobromide [(S)-AHT · HBr, 3] gave a mixture of diastereomer, which was separated by column chromatography on silica gel to obtain the single isomer 4. This synthetic method was unsuitable for large-scale synthesis, because of the ineffective diastereomer separation, the use of column chromatography, and the low reaction temperature.
We developed a synthetic strategy for KUR-1246, as shown in Chart 2, should be the condensation of the optically active halide 14 and the optically active amine 24 in order to avoid the above-mentioned difficulties. Furthermore, we planned the synthesis of the halide 14 by the asymmetric borane reduction of the phenacyl halide 13 that would be derived from 4Ј-hydroxyacetophenone (7). The amine 24 was prepared from (S )-2-amino-7-methoxytetraline [(S)-AMT].
The Synthesis of the Optically Pure (R)-Bromohydrin 14 The phenacyl bromide 13 was synthesized from the ketone 7 that was inexpensive and easily available in large quantity, as shown in Chart 3. The methyl ester 11 was obtained from 7 through chloromethylation, 3) cyanation with NaCN, hydrolysis with aqueous NaOH, and esterification with MeOH in the presence of H 2 SO 4 . The methyl ester 11 was reacted with benzyl chloride in the presence of KI and K 2 CO 3 to give the ketone 12 in 78% yield. The bromination of 12 with Br 2 gave 13 in 72% yield.
Recently, we reported the efficient catalysts prepared from aluminum triethoxide [Al(OEt) 3 ] and chiral amino alcohols for asymmetric borane reduction. 4) We investigated our asymmetric reduction methodology to obtain this optically active bromohydrin 14 from 13 (Chart 4). These results are summarized in Table 1 . The reaction of 13 with the borane dimethyl sulfide complex (BH 3 · Me 2 S) (120 mol%), Al(OEt) 3 (12 mol%) and (R)-a,a-diphenyl-2-pyrrolidinemethanol (15) (10 mol%) reduced both the ketone and the ester groups to give the crude 14 with 98.0% ee. After the recrystallization of the crude product, 14 was obtained in the good yield of 86% with the excellent optical purity of 99.9% ee (entry 1). The absolute configuration of the bromohydrin 14 was determined to be the R-configuration by X-ray crystallographic analysis using the anomalous dispersion effect of the bromine atoms, as shown in Fig. 2 . Furthermore, we examined the possibility of decreasing the quantity of 15. Using 5 mol% of 15 and 6 mol% of Al(OEt) 3 led to a good result (90% yield, 99.5% ee, entry 2). However, the further reduction in the amount of 15 to 2 mol% gave 14 with the unsatisfactory optical purity of 95.4% ee in spite of recrystallization (entry 3). And furthermore, 15 had to be prepared from expensive D-proline.
5)
The asymmetric borane reduction of acetophenone using the amino alcohol (ϩ)-18 prepared from (Ϫ)-camphor gave (R)-1-phenylethanol with 88% ee.
6) The result was suggested that the reduction of 13 using of (Ϫ)-18 prepared from inexpensive (ϩ)-camphor produced 14. (ϩ)-Camphor was easily converted to (Ϫ)-18, which included ca. 11% of the endo form, and the intricate purification via the cyclic carbamate was reported. 7) We found that (Ϫ)-18 was readily purified by recrystallization of its methanesulfonic acid salt (Chart 5). We then examined this asymmetric reduction using (Ϫ)-18. The optical purity of the crude product was 94.6% ee, and 14 was obtained in 85% yield with 98.3% ee after recrystallization (entry 4).
The Synthesis of the Optically Pure (S)-Amine 24
Some synthetic methods of the optically pure (S )-AMT have been reported 8) and we also published that (S)-AMT · HCl (20) was prepared from (R)-2-(3-methoxybenzyl)succinic acid. 9) The amine 20 was demethylated in 48% hydrobromic acid under reflux to (S)-AHT · HBr (3) in 99% yield. The reaction of 3 with di-tert-butyl dicarbonate (Boc 2 O) followed O-alkylation with 2-chloro-N,N-dimethylacetamide (22) gave the amide 23 in 76% yield. Compound 23 was treated with concentrated hydrochloric acid (conc. HCl) in iso-PrOH, and then the precipitate from the reaction solution was collected by filtration to give the amine 24 in 79% (Chart 6).
The Synthesis of KUR-1246 by Coupling of 14 and 24 These two optically active components, the bromohydrin 14 and the amine 24, were coupled to produce KUR-1246, as shown in Chart 7. The bromide 25, obtained from 14 with protection of the two hydroxyl groups using tert-butylchlorodimethylsilane (TBS-Cl), was reacted with 24 to give compound 26. The TBS ethers of the crude 26 were cleaved by ptoluenesulfonic acid (TosOH) in aqueous tetrahydrofuran (THF), followed by crystallization with oxalic acid to produce the oxalate 27 in 69% yield from 14. The benzyl group of the free amine of 27 underwent catalytic hydrogenolysis to give compound 28 in 89% yield. Finally, 0.5 M H 2 SO 4 (50 mol%) was added to a solution of 28 in MeOH, and then the precipitate was collected by filtration to give KUR-1246 in 87% yield.
In conclusion, we established an efficient and practical route for the synthesis of the optically active uterine relaxant KUR-1246 by the coupling of the optically active bromohydrin 14 and the optically active amine 24 prepared from 4Ј-hydroxyacetophenone (7) and (S)-AMT · HCl (20), respectively. Furthermore, the optically active bromohydrin 14 was prepared by the asymmetric borane reduction of the phenacyl bromide 13 using Al(OEt) 3 and the chiral amino alcohol 15 or (Ϫ)-18. a) The optical purity was measured by HPLC analysis using a chiral column (Chiralpak AD).
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Chart 7
Experimental
All melting points were determined on a Yanagimoto melting point apparatus and are uncorrected. IR spectra were recorded on a Nicolet 510 FT-IR spectrometer.
1 H-and 13 C-NMR spectra were recorded on a Bruker DRX-500 using tetramethylsilane or sodium 3-(trimethylsilyl)propionate-2,2,3,3-d 4 as the internal standard. Mass spectra were measured using a JEOL JMS-SX102A mass spectrometer. Optical rotations were measured with a JASCO DIP-370 polarimeter.
1-(3-Chloromethyl-4-hydroxyphenyl)ethanone (8) Formaldehyde (37% solution, 340 ml, 4.6 mol) was added to a suspension of 1-(4-hydroxyphenyl)ethanone (7) (136.0 g, 1.00 mol) in conc.HCl (1000 ml, 12.2 mol), and then the mixture was stirred for 4 h at 50°C. The resulting red precipitate was collected by filtration and washed with water to give 8 (203.2 g, wet, 110%) as a red solid. The solid was used for the next reaction without further purification. An analytical sample was prepared by recrystallization from THF as a white solid. mp 172-175°C. IR (5-Acetyl-2-hydroxyphenyl)acetic Acid (10) A suspension of NaCN (98.0 g, 2.00 mol) in dimethylsulfoxide (0.5 l) was stirred for 30 min at 60°C. Compound 8 (203.2 g, wet) in limited amounts was added to the mixture over 1 h and stirred for 1 h at the same temperature. A solution of NaOH (140.0 g, 3.50 mol) in water (0.5 l) was then added to the mixture and refluxed for 2 h. After cooling to room temperature, the mixture was diluted with water (2.5 l), washed with toluene (0.5 l), acidified with conc.HCl (0.4 l), and extracted with AcOEt (3ϫ1 l). The organic layers were combined, washed with water (1.0 l), dried over MgSO 4 , and concentrated under reduced pressure. Toluene (300 ml) was added dropwise to the suspension of the residue in AcOEt (100 ml) at 50°C, and then cooled. The precipitate was collected by filtration to give 10 (97.6 g, 50% from 7). Methyl (5-Acetyl-2-benzyloxyphenyl)acetate (12) A mixture of 11 (90.9 g, 440 mmol), benzylchloride (58.0 g, 460 mmol), KI (7.3 g, 44 mmol), and K 2 CO 3 (63.4 g, 460 mmol) in N,N-dimethylformamide (DMF) (150 ml) was stirred for 1.5 h at 50°C. Water (600 ml) was then added to the mixture and the precipitate was collected by filtration. The crude product was recrystallized from AcOEt-hexane to give 12 (101.4 g, 78% Methyl (2-Benzyloxy-5-bromoacetylphenyl)acetate (13) A solution of Br 2 (6.2 ml, 120 mmol) in hexane (15 ml) was added dropwise to a solution of 12 (32.8 g, 110 mmol) in AcOEt (160 ml) over 20 min. After 30 min, water was added to the mixture and the separated organic layer was washed with brine (50 ml), dried over MgSO 4 , and concentrated under reduced pressure. The resulting residue was recrystallized from AcOEt-hexane to give (17) 6) (8.52 g, 47 mmol) in ether (120 ml) was added dropwise to a suspension of LiAlH 4 (5.32 g, 140 mmol) in ether (140 ml) over 45 min at room temperature, and then stirred overnight. 2 M NaOH (25 ml) was carefully added to the mixture and the mixture was dried over MgSO 4 . The solid was removed by filtration, and the filtrate was concentrated under reduced pressure. A solution of methanesulfonic acid (4.50 g, 47 mmol) in ether (20 ml) was added to the solution of the obtained residue in ether (120 ml). The precipitate was collected by filtration to give the crude methansulfonic acid salt (10.4 g, 84%, (Ϫ)-18: endo-18ϭ88.9 : 11.1). The crude salt (8.00 g) was recrystallized twice from EtOH-hexane to give the pure salt 19 (3.25 g, 41%, (Ϫ)-18: endo-18ϭ99. 6 3 (59 mg, 0.36 mmol) was added to a solution of (R)-a,adiphenyl-2-pyrolidinylmethanol (15) (76 mg, 0.30 mmol) in THF (3 ml), and the mixture was stirred at room temperature for 1 h under a N 2 atmosphere. After BH 3 · Me 2 S (10 M, 0.6 ml, 6 mmol) was added, a solution of 13 (1.132 g, 3 mmol) in THF (6 ml) was added dropwise via a syringe pump over 1 h at 25°C. After 10 min, the mixture was stirred for 2 h at 50°C, quenched with MeOH (1 ml), and concentrated under reduced pressure. AcOEt (10 ml) and 1 M HCl (3 ml) were added to the resulting residue, and then the separated aqueous layer was extracted with AcOEt (10 ml). The organic layers were combined, washed with water (5 ml) and brine (5 ml), dried over MgSO 4 , and concentrated under reduced pressure. The resulting residue was recrystallized from AcOEt-hexane to give 14 (0.910 g, 86%) as a white solid. The ee of 14 was determined to be 99.9% by HPLC using a chiral column [column, Chiralpak AD 4.6 mm i.d.ϫ250 mm, Daicel Chemical Industries Co., Ltd.; mobile phase, hexane-iso-PrOH, 9 : 1; flow rate, . Intensity data were collected at room temperature using graphite monochromated Mo-Ka radiation (lϭ0.71069 Å) on a Rigaku RASA-7R diffractometer, 2q(max)ϭ55.0°. Of 4225 measured reflections, 2184 had IϾ3s, and 1893, including Bijvoet pairs, were unique and used for the structure analysis. The structure was solved by the direct method (SIR-92) and refined through full-matrix least square method to Rϭ0.042 and R w ϭ0.045 using the TEXSAN-TEXRAY Structure Analysis Package (Ver 1.9), Molecular Structure Corporation. Hydrogen atoms were incorporated at fixed position as with C-Hϭ0.95 Å. The absolute configuration was confirmed by refining the inverted configuration which converged to a higher residual of R/(R w )ϭ0.0716 / (0.0778) (heavy atoms only). The absolute configuration of 14 was confirmed to be R as shown in Fig. 2. (7S)-7-Amino-5,6,7,8-tetrahydro-2-naphtol Hydrobromide (3) A mixture of 20 (10.0 g, 48 mmol) and NaOH (2.3 g, 58 mmol) in water (40 ml) was extracted with toluene (2ϫ20 ml). The organic layers were combined, washed with water (10 ml), and concentrated under reduced pressure to give an oil. A mixture of the oil in 48% hydrobromic acid (27 ml) was refluxed for 4 h in a 140°C oil bath. After concentration under reduced pressure, the resulting residue was recrystallized from iso-PrOH to give 3 (11. (7S)-7-tert-Butoxycabonylamino-5,6,7,8-tetrahydro-2-naphthol (21) A solution of Boc 2 O (11.1 g, 51 mmol) in DMF (30 ml) was added dropwise to a mixture of 3 (11.3 g, 46 mmol) and triethylamine (32 ml, 230 mmol) in DMF (70 ml) cooled in an ice bath over 10 min, and then the mixture was stirred overnight at room temperature. Water (200 ml) was added to the mixture and extracted with AcOEt (2ϫ100 ml). The organic layers were combined, washed with water (100 ml), 4% citric acid (100 ml), water (100 ml), and brine (100 ml), dried over MgSO 4 , and concentrated under reduced pressure to give 21 (12.4 g, 102%) as a viscous oil. The oil was used for the next step without purification. An analytical sample was prepared by purification using silica gel chromatography (eluent; AcOEt : hexaneϭ1 : 2) that produced a colorless oil. IR 
2-{[(2S )-2-tert-Butyloxycabonylamino-1,2,3,4-tetrahydronaphthalen-7-yl]oxy}-N,N-dimethylacetamide (23)
A solution of 2-chloro-N,N-dimethylacetamide (22) (6.2 g, 51 mmol) in THF (10 ml) was added dropwise to a mixture of 21 (12.4 g, 46 mmol), KI (8.5 g, 51 mmol), NaOH (3.9 g, 98 mmol), water (20 ml), and THF (50 ml) at room temperature. After stirring for 0.5 h, 22 (1.7 g, 14 mmol) was added dropwise to the mixture. After stirring for 1 h, AcOEt (200 ml) was added and the organic solution was washed with water (100 ml) and brine (50 ml), dried over MgSO 4 , and concentrated under reduced pressure. bromo-1-tert-butyldimethylsilyloxyethane (25) A solution of TBS-Cl (32.18 g, 214 mmol) in toluene (32 ml) was added to a solution of 14 (30.00 g, 85 mmol) and imidazole (29.07 g, 427 mmol) in DMF (100 ml) cooled in an ice bath, and then the mixture was stirred at room temperature for 6 h. A solution of TBS-Cl (2.57 g, 17 mmol) in toluene (2.5 ml) was added to the reaction mixture. After 2 h, water (100 ml) was added to the mixture and extracted with AcOEt (2ϫ100 ml). The organic layers were combined, washed with water (2ϫ100 ml) and brine (50 ml), dried over MgSO 4 , and concentrated under reduced pressure to give 25 (52.2 g, 118%) as a colorless oil. The oil was used for the next step without purification. An analytical sample was prepared by purification using silica gel column chromatography (eluent; hexane) that produced a colorless oil. 
2-{[(2S )-2-({(2R)-2-[4-Benzyloxy-3-(2-tert-butyldimethylsilyloxyethyl)-phenyl]-2-tert-butyldimethylsilyloxyethyl}amino)-1,2,3,4-tetrahydronaphthalen-7-yl]oxy}-N,N-dimethylacetamide (26)
A mixture of 25 (58.2 g, 85 mmol), 24 (30.2 g, 94 mmol), and K 2 CO 3 (18.9 g, 137 mmol) in N,N-dimethylacetamide (85 ml) was stirred for 6 h under an argon atmosphere in a 120°C oil bath. After cooling to room temperature, water (200 ml) was added to the mixture and extracted with AcOEt (2ϫ200 ml). The organic layers were combined, washed with water (2ϫ100 ml) and brine (100 ml), dried over MgSO 4 , and concentrated under reduced pressure to give 26 (68.6 g, 108% from 14) as a brown oil. The oil was used for the next step without purification. An analytical sample was prepared by purification using silica gel column chromatography (eluent; CH 2 TosOH · H 2 O (48.7 g, 256 mmol) in THF (480 ml) and water (24 ml) was stirred at room temperature overnight. After the addition of a solution of K 2 CO 3 (39 g, 281 mmol) in water (300 ml), the mixture was extracted with AcOEt (300 ml) and 10% EtOH-AcOEt (300 ml). The organic layers were combined, washed with aqueous 0.4 M K 2 CO 3 solution (200 ml) and brine (200 ml), then concentrated under reduced pressure. A solution of oxalic acid dihydrate (10.7 g, 85 mmol) in EtOH (80 ml) was added to the solution of the resulting residue in EtOH (120 ml) at 50°C, and then toluene (430 ml) was added to the mixture and cooled to room temperature. The precipitate
